JUUL Labs Reaches Settlement with Thousands of Plaintiffs

Dec.07.2022
JUUL Labs Reaches Settlement with Thousands of Plaintiffs
JUUL Labs reaches settlement with thousands of plaintiffs in federal multi-district litigation over e-cigarette use.

JUUL Labs, a troubled electronic cigarette manufacturer, announced on Tuesday evening that they have reached a settlement with thousands of plaintiffs in various cases.


The company stated that the settlement of the federal multidistrict litigation, consolidated in the Northern District of California, represents a global resolution that covers "over 5,000 cases brought by approximately 10,000 plaintiffs against Juul Labs and its executives and directors.


Over the past year, Juul Labs has reached settlements with 37 states and territories, and we are still in discussions with other significant stakeholders to resolve remaining lawsuits," the company said in a statement. "As announced by the company in November, Juul Labs has taken a series of measures to stabilize its business operations and address past legal issues.


The terms of the settlement were not disclosed.


In almost constant litigation, an e-cigarette company allegedly associated with Altria (MO) narrowly avoided bankruptcy in early November.


2FIRSTS will continue to report on this topic and provide updates on the '2FIRSTS APP'. Scan the QR code below to download the app.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Heaven Gifts’s HNB Brand REJO Launches New Device with Design Strikingly Similar to ELFBAR JOINOne Series
Heaven Gifts’s HNB Brand REJO Launches New Device with Design Strikingly Similar to ELFBAR JOINOne Series
Miracle’s heated tobacco brand REJO has launched its new device REJO CUBE in Dubai. The device’s industrial design is highly similar to the ELFBAR JOINOne series, featuring a left-right magnetic structure and side-mounted screen. Positioning the Middle East as a key market, REJO is moving ahead with local team building and entity setup in the region.
Nov.14 by 2FIRSTS.ai
Two Malaysian Men Charged Over Illegal Import of  Vape Items at Singapore Checkpoint
Two Malaysian Men Charged Over Illegal Import of Vape Items at Singapore Checkpoint
Two Malaysian men arrested for illegally importing e-cigarettes at Woodlands Checkpoint, facing charges, court hearing on December 15. (20 words)
Nov.18 by 2FIRSTS.ai
ICYMI: E-cigarette registrations in the UK drop sharply in the latest MHRA update, with 317 new codes approved from Sept 15-21. Prominent brands like IVG and LOST MARY see new device releases, while pod registrations plummet by 82%, with JUUL making a rar
ICYMI: E-cigarette registrations in the UK drop sharply in the latest MHRA update, with 317 new codes approved from Sept 15-21. Prominent brands like IVG and LOST MARY see new device releases, while pod registrations plummet by 82%, with JUUL making a rar
MHRA publicly announced over 300 e-cigarette registration codes, showing a decrease in pod submissions and new brand devices.
Sep.22 by 2FIRSTS.ai
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai
2Firsts Monitor | FOGER website flags customs & tariff delays; some products out of stock
2Firsts Monitor | FOGER website flags customs & tariff delays; some products out of stock
2Firsts observed on FOGER’s online retail site “FOGER VAPES” that the platform indicates restocking delays due to customs and tariff factors. Several items show limited availability or “sold out” status, with a restock alert feature offered. A previous article on the site also referenced potential tariff changes that may affect pricing.
Nov.05
KT&G to Complete New Indonesian Factory, Its Largest Overseas Production Hub
KT&G to Complete New Indonesian Factory, Its Largest Overseas Production Hub
According to Daily Hankooki, KT&G’s new factory in Indonesia will be completed this month and is scheduled to begin operations in February 2026. Once operational, the facility will have an annual production capacity of around 35 billion cigarettes, becoming the company’s largest overseas manufacturing base.
Nov.12 by 2FIRSTS.ai